As part of the agreement GlaxoSmithKline Biologicals (GSK) is acquiring exclusive rights to develop and commercialize two Alzheimer’s disease vaccine candidates that are based on AFFiRiS AFFiTOPE technology
IT-101 is an experimental, nanoparticle therapeutic that consists of the drug camptothecin conjugated to a cyclodextrin polymer. IT-101, the first drug candidate in Calando’s proprietary Cyclosert pipeline, has
The latest analysis focused on a prospective group of patients (n=50) with an annualized relapse rate (ARR) of greater than one at study entry which is comparable to
This investigational study shows that the combination inhibits the growth of prostate cancer cell lines in various model systems. This data provide the scientific rationale for an ongoing
Most recently, Mr Arlotta has served as chairman, president and CEO of Coram, a provider of specialty infusion and pharmacy distribution services that was acquired by Apria Healthcare
Asenapine, which is administered as a fast-dissolving sublingual tablet, is a psychopharmacologic compound with a unique human receptor signature, said Schering-Plough. The study was a randomized, placebo-controlled, double-blind,
Synexus hopes to have the new sites completed by March 2009. Synexus, which acquired the clinical trial business CRC in 2006, said that it has found South Africa
Celera will use Nanogen’s minor groove binder (MGB) technology to develop in vitro diagnostic products for cardiovascular and oncological applications. This is an expansion of the original license
Dr Rothenberg comes to Pfizer from Vanderbilt where he was professor of medicine at the Vanderbilt University Medical Center and Ingram professor of cancer research at the Vanderbilt-Ingram
The challenge to validity was made by way of an application by Generics UK for a declaration that the supplementary protection certificate (SPC) and the patent on which
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.